Cargando…
Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer
CD46 is generally overexpressed in many human cancers, representing a prime target for CD46-binding adenoviruses (Ads). This could help to overcome low anti-tumoral activity by coxsackie-adenoviral receptor (CAR)-targeting cancer gene therapy viruses. However, because of scarce side-by-side informat...
Autores principales: | Do, Manh-Hung, To, Phuong Kim, Cho, Young-Suk, Kwon, Se-Young, Hwang, Eu Chang, Choi, Chan, Cho, Sang-Hee, Lee, Sang-Jin, Hemmi, Silvio, Jung, Chaeyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164063/ https://www.ncbi.nlm.nih.gov/pubmed/30201920 http://dx.doi.org/10.3390/ijms19092694 |
Ejemplares similares
-
Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers
por: Cho, Young-Suk, et al.
Publicado: (2016) -
CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity
por: Do, Manh-Hung, et al.
Publicado: (2022) -
Complement Regulatory Protein CD46 Manifests a Unique Role in Promoting the Migration of Bladder Cancer Cells
por: Nguyen, Thuy Thi, et al.
Publicado: (2023) -
Zinc Inhibits Expression of Androgen Receptor to Suppress Growth of Prostate Cancer Cells
por: To, Phuong Kim, et al.
Publicado: (2018) -
Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics
por: To, Phuong Kim, et al.
Publicado: (2020)